|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$1.34 |
$1.49 |
$1.32 |
$1.44 |
1.67M | 03/25/2024 |
$1.46 |
$1.56 |
$1.42 |
$1.44 |
1.18M | 03/26/2024 |
$1.45 |
$1.57 |
$1.38 |
$1.52 |
1.20M | 03/27/2024 |
$1.55 |
$1.62 |
$1.47 |
$1.58 |
1.18M | 03/28/2024 |
$1.65 |
$1.65 |
$1.53 |
$1.58 |
1.07M |
|
Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular. | |
|
Adaptimmune Therapeutics PLC (ADAP) has the following price history information. Looking back at ADAP historical stock prices for the last five trading days, on March 22, 2024, ADAP opened at $1.34, traded as high as $1.49 and as low as $1.32, and closed at $1.44. Trading volume was a total of 1.67M shares. On March 25, 2024, ADAP opened at $1.46, traded as high as $1.56 and as low as $1.42, and closed at $1.44. Trading volume was a total of 1.18M shares. On March 26, 2024, ADAP opened at $1.45, traded as high as $1.57 and as low as $1.38, and closed at $1.52. Trading volume was a total of 1.20M shares. On March 27, 2024, ADAP opened at $1.55, traded as high as $1.62 and as low as $1.47, and closed at $1.58. Trading volume was a total of 1.18M shares. On March 28, 2024, ADAP opened at $1.65, traded as high as $1.65 and as low as $1.53, and closed at $1.58. Trading volume was a total of 1.07M shares.
ADAP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adaptimmune Therapeutics PLC shares, starting with a $10,000 purchase of ADAP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/07/2015 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$17.23 |
|
End price/share: |
$1.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-90.83% |
|
Average Annual Total Return: |
-23.55% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$916.68 |
|
Years: |
8.90 |
|
|
|
Date |
Close |
03/22/2024 | $1.44 | 03/25/2024 | $1.44 | 03/26/2024 | $1.52 | 03/27/2024 | $1.58 | 03/28/2024 | $1.58 |
|
|